SUBLOCADE

Google image searchProduct monograph

Active ingredient

buprenorphine, 300 MG/1.5 ML

DIN: 02483092

Dosage form(s): SOLUTION (EXTENDED RELEASE)

Route(s) of administration: SUBCUTANEOUS

Description: PREFILLED SYRINGE & POUCH - SINGLE DOSE

Schedule: Narcotic (CDSA I)

Company: INDIVIOR UK LIMITED

Date: 03-FEB-2020

ATC:

Reference brand drug: Butrans

Pharmaceutical standard: PH EUR

Search on Google